Promoting Safe Medication Use in Pregnancy in the Era of Real-World Data - The SafeStart Study

NACompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

October 31, 2021

Study Completion Date

November 27, 2023

Conditions
Pregnancy EarlyEmesisMedication Adherence
Interventions
OTHER

Pharmacist consultation

"The intervention is a patient-centered consultation that will last about 15 minutes. The intervention is defined as A planned, individualized, and structured conversation with the purpose to relieve pregnant women for any concern and answer questions she may have regarding self-care ailments and medication use in pregnancy. Specifically, the consultation will:~* Answer any questions the participants may have within pharmaceutical care.~* Improve pregnant women's understanding of common pregnancy-related ailments and hence contribute to better management of the ailments.~* Raise awareness, provide confidence, and give information about safe medications options in pregnancy~* Focus on preventative measures for NVP.~* Contribute to better adherence for needed/chronic medication throughout the pregnancy.~The pharmacists will beforehand have access to the women´s answers from the baseline questionnaire Q1, including information about her medical conditions and medication use."

Trial Locations (1)

0371

Department of Pharmacy, University of Oslo, Oslo

All Listed Sponsors
lead

Hedvig Marie Egeland Nordeng

OTHER

NCT04182750 - Promoting Safe Medication Use in Pregnancy in the Era of Real-World Data - The SafeStart Study | Biotech Hunter | Biotech Hunter